FONAR (FONR) Competitors $13.73 -0.23 (-1.65%) As of 02:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FONR vs. SMTI, STIM, SNWV, ZIMV, NVRO, TCMD, SKIN, NYXH, DRTS, and ELMDShould you be buying FONAR stock or one of its competitors? The main competitors of FONAR include Sanara MedTech (SMTI), Neuronetics (STIM), SANUWAVE Health (SNWV), ZimVie (ZIMV), Nevro (NVRO), Tactile Systems Technology (TCMD), Beauty Health (SKIN), Nyxoah (NYXH), Alpha Tau Medical (DRTS), and Electromed (ELMD). These companies are all part of the "medical equipment" industry. FONAR vs. Sanara MedTech Neuronetics SANUWAVE Health ZimVie Nevro Tactile Systems Technology Beauty Health Nyxoah Alpha Tau Medical Electromed Sanara MedTech (NASDAQ:SMTI) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, community ranking, valuation, analyst recommendations, institutional ownership, earnings and risk. Does the MarketBeat Community prefer SMTI or FONR? FONAR received 157 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 74.79% of users gave FONAR an outperform vote while only 61.54% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes2461.54% Underperform Votes1538.46% FONAROutperform Votes18174.79% Underperform Votes6125.21% Do analysts recommend SMTI or FONR? Sanara MedTech presently has a consensus target price of $49.50, suggesting a potential upside of 59.73%. Given Sanara MedTech's stronger consensus rating and higher possible upside, analysts plainly believe Sanara MedTech is more favorable than FONAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00FONAR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings and valuation, SMTI or FONR? FONAR has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M3.18-$4.30M-$1.34-23.13FONAR$103.02M0.84$10.57M$1.2511.17 Which has more volatility and risk, SMTI or FONR? Sanara MedTech has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500. Does the media favor SMTI or FONR? In the previous week, Sanara MedTech had 12 more articles in the media than FONAR. MarketBeat recorded 13 mentions for Sanara MedTech and 1 mentions for FONAR. Sanara MedTech's average media sentiment score of 0.57 beat FONAR's score of 0.42 indicating that Sanara MedTech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanara MedTech 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FONAR 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is SMTI or FONR more profitable? FONAR has a net margin of 7.68% compared to Sanara MedTech's net margin of -10.71%. FONAR's return on equity of 4.94% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% FONAR 7.68%4.94%3.70% Do institutionals & insiders hold more shares of SMTI or FONR? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by company insiders. Comparatively, 1.6% of FONAR shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryFONAR beats Sanara MedTech on 10 of the 18 factors compared between the two stocks. Get FONAR News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFONARElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$86.59M$3.15B$5.33B$8.39BDividend YieldN/A1.72%5.21%4.10%P/E Ratio12.1417.0926.7719.70Price / Sales0.8498.95393.27122.35Price / Cash4.7844.0938.2534.62Price / Book0.543.736.774.50Net Income$10.57M$94.03M$3.23B$248.22M7 Day Performance8.22%0.63%0.43%-0.80%1 Month Performance14.43%20.28%9.07%11.52%1 Year Performance-8.82%-9.18%18.57%8.99% FONAR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFONAR1.7838 of 5 stars$13.73-1.6%N/A-9.7%$85.17M$103.02M11.94480High Trading VolumeSMTISanara MedTech1.7856 of 5 stars$34.37+6.2%$48.50+41.1%+2.3%$305.48M$86.67M-34.7260High Trading VolumeSTIMNeuronetics2.1205 of 5 stars$4.14-6.5%$5.50+32.9%+69.1%$272.47M$74.89M-3.37180Gap UpSNWVSANUWAVE HealthN/A$30.55+1.5%N/AN/A$261.17M$32.63M-6.7040ZIMVZimVie2.1995 of 5 stars$8.91+1.7%$19.50+118.9%-52.1%$248.12M$449.75M-0.682,700NVRONevro0.2018 of 5 stars$5.85+0.1%$5.36-8.3%-40.4%$224.32M$408.52M-3.091,090TCMDTactile Systems Technology3.3262 of 5 stars$9.72+1.9%$16.00+64.6%-24.1%$221.79M$293.16M13.89980Positive NewsSKINBeauty Health0.3748 of 5 stars$1.76-5.9%$2.45+39.2%-34.5%$220.43M$322.47M-4.191,030High Trading VolumeNYXHNyxoah2.952 of 5 stars$5.98-5.1%$14.50+142.5%-19.1%$203.68M$4.52M-3.20110Gap DownDRTSAlpha Tau Medical1.9741 of 5 stars$2.80-5.1%$8.00+185.7%+10.7%$197.07MN/A-6.5180Earnings ReportELMDElectromed1.5173 of 5 stars$22.44+0.8%$38.00+69.3%+24.2%$192.02M$59.63M29.92160Positive NewsGap Down Related Companies and Tools Related Companies Sanara MedTech Competitors Neuronetics Competitors SANUWAVE Health Competitors ZimVie Competitors Nevro Competitors Tactile Systems Technology Competitors Beauty Health Competitors Nyxoah Competitors Alpha Tau Medical Competitors Electromed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FONR) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FONAR Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share FONAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FONR Stock Free FONR Stock Alerts